188 related articles for article (PubMed ID: 30325059)
1. Power priors based on multiple historical studies for binary outcomes.
Gravestock I; Held L
Biom J; 2019 Sep; 61(5):1201-1218. PubMed ID: 30325059
[TBL] [Abstract][Full Text] [Related]
2. Adaptive power priors with empirical Bayes for clinical trials.
Gravestock I; Held L;
Pharm Stat; 2017 Sep; 16(5):349-360. PubMed ID: 28574202
[TBL] [Abstract][Full Text] [Related]
3. Modified power prior with multiple historical trials for binary endpoints.
Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
[TBL] [Abstract][Full Text] [Related]
4. Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials.
Ohigashi T; Maruo K; Sozu T; Gosho M
Stat Methods Med Res; 2022 Jul; 31(7):1392-1404. PubMed ID: 35379046
[TBL] [Abstract][Full Text] [Related]
5. Robust meta-analytic-predictive priors in clinical trials with historical control information.
Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
[TBL] [Abstract][Full Text] [Related]
6. A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.
Isogawa N; Takeda K; Maruo K; Daimon T
Ther Innov Regul Sci; 2020 May; 54(3):559-570. PubMed ID: 33301135
[TBL] [Abstract][Full Text] [Related]
7. Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information.
Li JX; Chen WC; Scott JA
J Biopharm Stat; 2016; 26(6):1056-1066. PubMed ID: 27541990
[TBL] [Abstract][Full Text] [Related]
8. Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
Brard C; Hampson LV; Gaspar N; Le Deley MC; Le Teuff G
BMC Med Res Methodol; 2019 Apr; 19(1):85. PubMed ID: 31018832
[TBL] [Abstract][Full Text] [Related]
9. A novel power prior approach for borrowing historical control data in clinical trials.
Shi Y; Li W; Liu GF
Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
[TBL] [Abstract][Full Text] [Related]
10. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.
Hobbs BP; Carlin BP; Mandrekar SJ; Sargent DJ
Biometrics; 2011 Sep; 67(3):1047-56. PubMed ID: 21361892
[TBL] [Abstract][Full Text] [Related]
11. Bayesian design of noninferiority trials for medical devices using historical data.
Chen MH; Ibrahim JG; Lam P; Yu A; Zhang Y
Biometrics; 2011 Sep; 67(3):1163-70. PubMed ID: 21361889
[TBL] [Abstract][Full Text] [Related]
12. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
Bennett M; White S; Best N; Mander A
Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
[TBL] [Abstract][Full Text] [Related]
13. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
Hupf B; Bunn V; Lin J; Dong C
Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
[TBL] [Abstract][Full Text] [Related]
14. Quantification of prior impact in terms of effective current sample size.
Wiesenfarth M; Calderazzo S
Biometrics; 2020 Mar; 76(1):326-336. PubMed ID: 31364156
[TBL] [Abstract][Full Text] [Related]
15. Historical controls in clinical trials: a note on linking Pocock's model with the robust mixture priors.
Callegaro A; Galwey N; Abellan JJ
Biostatistics; 2023 Apr; 24(2):443-448. PubMed ID: 37057610
[TBL] [Abstract][Full Text] [Related]
16. Incorporating historical information in biosimilar trials: Challenges and a hybrid Bayesian-frequentist approach.
Mielke J; Schmidli H; Jones B
Biom J; 2018 May; 60(3):564-582. PubMed ID: 29532950
[TBL] [Abstract][Full Text] [Related]
17. Empirical Bayes models of Poisson clinical trials and sample size determination.
Zaslavsky BG
Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
[TBL] [Abstract][Full Text] [Related]
18. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
Feißt M; Krisam J; Kieser M
Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
[TBL] [Abstract][Full Text] [Related]
19. Using historical control information for the design and analysis of clinical trials with overdispersed count data.
Gsteiger S; Neuenschwander B; Mercier F; Schmidli H
Stat Med; 2013 Sep; 32(21):3609-22. PubMed ID: 23722585
[TBL] [Abstract][Full Text] [Related]
20. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
Warren JL; Wang Q; Ciarleglio MM
Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]